72 results
Page 3 of 4
8-K
EX-99.1
p27iich7gpo
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-99.1
3i2xjau1
22 Apr 21
Yumanity Therapeutics’ YTX-7739 Achieved Target Engagement at Doses That Were Generally Well Tolerated
7:11am
424B5
03f52b7g
8 Apr 21
Prospectus supplement for primary offering
8:58am
424B3
zwth63zzomg fusdg6
11 Feb 21
Prospectus supplement
4:55pm
8-K/A
EX-99.7
4wbv2kt
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.2
cinz0h31
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
54xblgo stzbx2
3 Feb 21
Other Events
4:59pm
8-K
EX-99.1
yblxxvap6j
11 Jan 21
Regulation FD Disclosure
6:30am
8-K
EX-99.1
p3l9s62vx6k2mruj
4 Dec 20
Other Events
5:17pm
425
EX-99.1
bedc9j2jr2we jg52
4 Dec 20
Business combination disclosure
5:16pm
424B3
25mop6 nx
12 Nov 20
Prospectus supplement
6:08am
S-4/A
EX-10.17
yi6dft 03pzilb
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4/A
0zu8nm1ju 5xe
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4
zxvyt z3w1cpf82
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm